UCL researchers have developed an ultrasound helmet that enables deep brain stimulation without surgery, offering hope for Parkinson's and other neurological disorders.
The approval of the Moderna COVID vaccine in the UK comes 2 days after European medical regulators, but not a moment too soon - the death toll continues to climb, standing at 78,508 currently.
Damaged heart muscle is a tragic possibility for patients of breast cancer chemotherapy - but thanks to Dr Husam Abdel-Qadir, there may now be a way to stop it.
Salk Institute scientists believe they have solved this mystery for bipolar disorder patients - the answer involves a specific gene, and proposes changes to the future of treatment.
John Grimm, Vice President of Strategy and Business Development at Entrust, shares his advice on how health organisations can minimise the chances of a security breach at a time when resources are stretched more than ever.
Timothy Kwok, Professor at The Chinese University of Hong Kong, tells us about the Electronic Cognitive Screen (EC-Screen) that gives a brief and user-friendly digital cognitive test for the detection of dementia in older people.
Phillip P. Chan, MD, PhD, Chief Executive Officer of CytoSorbents Corporation (NASDAQ: CTSO), discusses the use of CytoSorb, a broad-spectrum blood purification technology to treat cytokine storm and hyperinflammation in critically ill COVID-19 patients.
The independent experts of the FDA say the Pfizer vaccine is good to go, which means that the COVID vaccine should be formally approved in a matter of days.
In this interview, Prof Christophe Drouet (CNRS Senior Scientist) – an international specialist in bio-inspired apatites – relates the multifunctional potential of these intrinsically biocompatible compounds for a wealth of uses from bone tissue repair, to cell-scale medicine.
Here, we look into the many ways in which medical and safety technology manufacturer Dräger has been stepping up to help its customers through the COVID-19 crisis.
